Trials / Completed
CompletedNCT05623046
Building Emotional Self-Awareness Teletherapy (BEST)
Building Emotional Self-Awareness Teletherapy (BEST): a Tool to Optimize Psychological Health Outcomes for Persons with Traumatic Brain Injury
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To examine the feasibility, acceptability, and preliminary efficacy of a remotely delivered intervention for civilians and service members with mild traumatic brain injury (mTBI) who have difficulty recognizing and regulating their emotions. Post-treatment outcomes of interest include emotional self-awareness and regulation, resiliency, and affective symptoms.
Detailed description
This Phase I proof of principle pilot study of the Building Emotional Self-awareness Teletherapy (BEST) intervention will use a quasi-experimental, non-randomized, one-group pretest-posttest design with a double pretest and a 3-month follow-up in approximately 40 participants with mTBI (\~20 civilians and \~20 service members). Study objectives are to explore the feasibility and early efficacy of BEST to improve psychological health outcomes in civilian and Service Member (SM) participants with mTBI who have alexithymia (poor emotional self-awareness) and emotion dysregulation. We anticipate BEST will have good feasibility and acceptability in both civilian and service member participants, and post-treatment assessments will show significant improvements in alexithymia, emotion regulation, resiliency, and affective symptoms.
Conditions
- Concussion, Mild
- Concussion, Brain
- Concussion, Severe
- Concussion, Intermediate
- Concussion; Syndrome
- Concussion Injury of Cerebrum
- Concussion with Brief Loss of Consciousness
- Alexithymia
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Treatment | 8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes |
Timeline
- Start date
- 2023-02-23
- Primary completion
- 2025-03-13
- Completion
- 2025-03-25
- First posted
- 2022-11-21
- Last updated
- 2025-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05623046. Inclusion in this directory is not an endorsement.